Canadian Agency for Drugs and Technologies in Health. (2018). Pharmacoeconomic review report Tocilizumab (Actemra) (Hoffman-La Roche Limited). Canadian Agency for Drugs and Technologies in Health.
Cita Chicago Style (17a ed.)Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report Tocilizumab (Actemra) (Hoffman-La Roche Limited). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2018.
Cita MLA (9a ed.)Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report Tocilizumab (Actemra) (Hoffman-La Roche Limited). Canadian Agency for Drugs and Technologies in Health, 2018.
Precaución: Estas citas no son 100% exactas.